Voute
Voute is recorded as a service provider in 8 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 8 of 8 trials · Latest update first
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson’s Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
Sponsor Bial R&D Investments S.A.
- Start (EU)
- Latest update
- Estimated end
Operational learnings available3 trial-level findings · Read insights
- The study screened and enrolled 1,048 participants in genetic-screening Part A versus an estimate of up to 3,750 needed to randomize approximately 237 participants, and randomized 272 participants.
- The trial operated at 86 sites across 11 countries, including 44 sites in nine European countries.
- Among randomized participants, 230 (84.6%) completed dosing, and treatment exposure and compliance were high, comparable between groups, and stable throughout the study.
These findings describe the trial, not the service provider’s performance or responsibility.
A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Intravenous Sabirnetug in Early Alzheimer’s Disease
Sponsor Acumen Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Dosing of Exidavnemab in Patients with Mild to Moderate Parkinson’s Disease on Stable Symptomatic Parkinson’s Disease Medication and in Patients with Multiple System Atrophy
Sponsor BioArctic AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase I/Ib Dose Escalation and Cohort Expansion Study of OMX-0407 a Salt-inducible Kinase inhibitor in patients with previously treated unresectable solid tumours
Sponsor iOmx Therapeutics AG
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutation
Sponsor Dizal Pharmaceutical Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.
Sponsor Bioprojet Pharma
- Start (EU)
- Latest update
- Estimated end
A multicentre, randomised, double-blind, placebo-controlled, 12-week parallel-group trial to evaluate the efficacy and safety of oral BP1.7881 in adult patients with moderate-to-severe atopic dermatitis
Sponsor Bioprojet Pharma
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Global Multicenter, Randomized, Double-blinded, Propofol-controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of HSK3486 Injectable Emulsion for Induction of General Anesthesia in Adults Undergoing Elective Surgery
Sponsor Haisco-USA Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Voute?
The 2026-10-09 snapshot links Voute to 8 distinct CTIS trials. Recorded services include Patient reimbursement, EU patient reimbursement solutions, Management of reimbursements for participants in the clinical trial, Participant Reimbursement, among 7 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Voute?
The most frequently recorded therapeutic areas are Neurology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Voute conducted?
The linked trials record locations in 11 countries, including Spain, France, Poland, Germany, Italy. These are trial locations, not confirmed office locations or countries where Voute delivered services.
What can this page tell me about Voute's trial experience?
Browse 8 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Voute. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Voute